After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
Stocks Info
KalVista Pharmaceuticals Inc is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Biotechnology industry. The current market capitalization of KalVista Pharmaceuticals Inc is $532.48M. A total of 1.05 million shares were traded on the day, compared to an average of 350.04K shares.
In the most recent transaction, Audhya Paul K. sold 2,394 shares of KALV for 10.02 per share on Feb 24 ’25. After the transaction, the CHIEF MEDICAL OFFICER now owns 102,940 company shares. In a previous transaction on Feb 24 ’25, Yea Christopher sold 1,918 shares at 10.02 per share. KALV shares that CHIEF DEVELOPMENT OFFICER owns now total 93,952.
Among the insiders who sold shares, Yea Christopher disposed of 2,601 shares on Feb 18 ’25 at a per-share price of $9.82. This resulted in the CHIEF DEVELOPMENT OFFICER holding 92,745 shares of KALV after the transaction. In another insider transaction, Audhya Paul K. sold 3,125 shares at $9.82 per share on Feb 18 ’25. Company shares held by the CHIEF MEDICAL OFFICER now total 100,334.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. In terms of 52-week highs and lows, KALV has a high of $15.50 and a low of $7.30.
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. KALV’s latest balance sheet shows that the firm has $166.20M in Cash & Short Term Investments as of fiscal 2022. There were $8.19M in debt and $11.58M in liabilities at the time. Its Book Value Per Share was $3.10, while its Total Shareholder’s Equity was $185.09M.
Analysts Opinion
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for KALV is Buy with a score of 4.89.
